|
|
|
CONE DYSTROPHY The retina or light sensitive membrane in the eye must remain intact and healthy to provide good vision. Two types of cells
are light sensitive and detect light, projecting their response back to the
brain via the optic nerve to be decoded and interpreted as "sight". The
Cones are cells which are responsible for daylight vision, they
distinguish fine detail, colour and form. They are concentrated close to the
fixation area of the eye- the macula. Their function enables us to recognise
faces, to read print and distinguish colours.
The
Rods are more numerous. They are very sensitive cells so are useful in
dim lights to maintain our night vision. Our peripheral (or side vision)
depends on their function. They detect movement and shapes helping us to
navigate in crowds or around obstacles. If
their function deteriorates we have difficulty distinguishing fine detail, the
change in colour vision can be more subtle. Because the eye is then depending
on the rods- very sensitive cells- bright lights become a problem. Vision
tests fail because interpretation of detail fails. INHERITANCE:
The cone
dystrophies are a heterogeneous group of inherited disorders- they may be
dominantly or recessively inherited. In the former case normally other members
of the family are known to be affected. While in the recessively inherited
group there is usually no positive family history- however siblings may also
have the problem (each have a 1 in 4 chance of contracting the disorder). The
children of an affected person are unlikely to be affected. SYMPTOMS:
Photophobia-
dislike of lights, reduced visual acuity and abnormal colour vision. AGE
OF ONSET: between
10 and 30 years DIAGNOSIS:
Retinal
change - Early a change in central areas may produce a "Bullseye
pattern". In some forms of
the condition diffuse pigmentary changes occur later. Tests
of retinal function including Ganzfeld electroretinography (ERG) which
shows reduced or absent cone responses is essential for the diagnosis. Tests
for colour vision are complementary (Farnsworth-Munsell 100-hue test). GENETIC
TESTING: Cone
dystrophy and cone-rod dystrophy (as
in Stargardt's disease, Best's disease, pattern dystrophy) have been mapped to
different regions of the genome, however the underlying genetic mutations
await identification. At the present time genetic testing of individual
patients with Cone Dystrophy is not of value. This may change at any
time. PROGNOSIS:
Impossible
to predict. The condition may be stationary or progressive. Serial tests are
necessary to determine prognosis. Peripheral vision and independent mobility
is usually maintained for many years. Reading can usually be maintained to a
late age with a variety of spectacles aids. THERAPY:
Supportive
aid is required. Regular checks to determine if lenses are required.There is
no means of treatment at this stage. Gene therapy may be available in the future. · Photos of Bullseye Macula and affected ERG will be added to this page soon. References: 1. Simunovic MP. Moore AT, The cone dystrophies Eye. 12 ( Pt 3b):553-65, 1998 2. Sadowski B. Zrenner E Cone and rod function in cone degenerations. Vision Research. 37(16):2303-14, 1997 3. Molecular genetics of central retinal dystrophies A & N Z J Ophthalmology. 24(3):189-98, 1996 Aug. 4. Sadowski B. Zrenner E . Differential diagnosis of cone dystrophies Ophthalmologe. 91(6):719-29, 1994 Dec. 5. Jacobson DM. Thompson HS. Bartley JA . X-linked progressive cone dystrophy. Ophthalmology. 96(6):885-95, 1989 Jun.
|
|
|